(5S,8S,11S,14S,17S,20S,23S,26R,29S,32S,35S)-5-Amino-20-[(2S)-2-butanyl]-6,13,16,19,24,31-hexahydroxy-11-[(1R)-1-hydroxyethyl]-35-(2-hydroxy-2-iminoethyl)-23-(3-hydroxy-3-iminopropyl)-8-[4-({hydroxy[(2R,3R)-3-methyl-3,4-dihydro-2H-pyrrol-2-yl]methylene}amino)butyl]-17-isopropyl-14,32-dimethyl-29-[2-(methylsulfanyl)ethyl]-9,10,27,28-tetraoxo-26-(selanylmethyl)-2-thia-7,12,15,18,21,22,25,30,33,34-decaazahexatriaconta-6,12,15,18,24,30-hexaen-36-oic acid
更新时间:2026-04-08 16:43:29
采购访问:5次
产品详情(用途,包装等)
用途: Motavizumab(MEDI-524)是一种抗人呼吸道合胞病毒(RSV)单克隆抗体。Motavizumab可用于高危婴儿呼吸道合胞病毒感染的研究[1]。 物理化学性质: CAS号:677010-34-3 常用中文名:Motavizumab 常用英文名:Motavizumab 分子式:C55H95N15O16S2Se 分子量:1365.524 密度:N/A 沸点:1323.5±75.0 °C at 760 mmHg 熔点:N/A 闪点:754.2±37.1 °C
|